微创部分与全肾上腺切除术治疗单侧原发性醛固酮增多症的回顾性多中心配对分析
本研究为回顾性多中心配对分析,纳入234例单侧原发性醛固酮增多症患者,比较微创部分与全肾上腺切除术的疗效与并发症。结果显示两组临床和生化成功率及围术期并发症发生率相当,但全切组术后皮质醇减少症和低血糖发生率更高。
要点
- 微创部分肾上腺切除术治疗单侧原发性醛固酮增多症的手术结局与全切相当。
- 全切术后皮质醇减少症和低血糖发生率显著高于部分切除。
- 部分切除可作为单侧原发性醛固酮增多症的优选术式。
核心结论
- 单侧原发性醛固酮增多症患者适合行微创部分肾上腺切除术,手术结局与全切相当且可能降低术后并发症。
研究设计与样本
- 回顾性多中心配对分析,纳入234例匹配的单侧原发性醛固酮增多症患者。
主要发现
- 全队列完全临床成功率40.6%,部分临床成功额外52.6%,完全生化成功率94.0%。
- 两组成功率和围术期并发症发生率相当。
- 术后皮质醇减少症发生率部分切除11.5% vs 全切25.0%(P < .001)。
- 术后低血糖发生率部分切除2.6% vs 全切7.1%(P = .039)。
关键数值与推荐
- 采用Primary Aldosteronism Surgical Outcome Study分类评估临床和生化成功。
- 78例(33.3%)行微创部分肾上腺切除术,156例(66.7%)行全肾上腺切除术。
临床怎么用
- 对于单侧原发性醛固酮增多症,可优先考虑微创部分肾上腺切除术以保留肾上腺皮质功能。
- 术后应关注皮质醇减少症和低血糖的发生,尤其在全切术后。
局限性
- 回顾性研究设计可能存在选择偏倚。
- 匹配对分析虽减少偏倚,但无法完全排除混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary hyperaldosteronism is a recognized risk factor for myocardial infarction, stroke, and atrial fibrillation. Minimally invasive adrenalectomy is the first-line treatment for localized primary hyperaldosteronism. Whether minimally invasive adrenalectomy should be performed using a cortex-sparing technique (partial minimally invasive adrenalectomy) or not (total minimally invasive adrenalectomy) remains a subject of debate. The aim of our study was to evaluate the clinical and biochemical efficacy of both procedures and to examine the morbidity associated with partial minimally invasive adrenalectomy versus total minimally invasive adrenalectomy in a multicenter study. METHODS: Using a retrospective study design, we determined the efficacy, morbidity, and mortality of partial minimally invasive adrenalectomy and total minimally invasive adrenalectomy. The Primary Aldosteronism Surgical Outcome Study classification was used to explore clinical and biochemical success. Matched-pair analysis was used in order to address possible bias. RESULTS: We evaluated 234 matched patients with unilateral primary hyperaldosteronism: 78 (33.3%) underwent partial minimally invasive adrenalectomy, and 156 (66.7%) were treated with total minimally invasive adrenalectomy. Complete clinical success was achieved in 40.6%, and partial clinical success in an additional 52.6% of patients in the entire cohort. Complete biochemical success was seen in 94.0% of patients. Success rates and the incidence of perioperative complications were comparable between groups. Both postoperative hypocortisolism (11.5% vs 25.0% after partial minimally invasive adrenalectomy and total minimally invasive adrenalectomy, respectively; P < .001) and postoperative hypoglycemia (2.6% vs 7.1% after partial minimally invasive adrenalectomy and total minimally invasive adrenalectomy; P = .039) occurred more frequently after total minimally invasive adrenalectomy. CONCLUSION: Our study provides evidence that patients with unilateral primary hyperaldosteronism are good surgical candidates for partial minimally invasive adrenalectomy. Not only is the surgical outcome comparable to that of total minimally invasive adrenalectomy, but also postsurgical morbidity, particularly in terms of hypocortisolism and hypoglycemia, may be reduced.
引用
- Billmann F, Billeter A, Thomusch O, et al. Minimally invasive partial versus total adrenalectomy for unilateral primary hyperaldosteronism-a retrospective, multicenter matched-pair analysis using the new international consensus on outcome measures. Surgery. 2020. PMID: 33077201. doi:10.1016/j.surg.2020.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。